Cargando…
Integrated fragmentomic profile and 5-Hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA
BACKGROUND: Using epigenetic markers and fragmentomics of cell-free DNA for cancer detection has been proven applicable. METHODS: We further investigated the diagnostic potential of combining two features (epigenetic markers and fragmentomic information) of cell-free DNA for detecting various types...
Autores principales: | Zhang, Zhidong, Pi, Xuenan, Gao, Chang, Zhang, Jun, Xia, Lin, Yan, Xiaoqin, Hu, Xinlei, Yan, Ziyue, Zhang, Shuxin, Wei, Ailin, Guo, Yuer, Liu, Jingfeng, Li, Ang, Liu, Xiaolong, Zhang, Wei, Liu, Yanhui, Xie, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209323/ https://www.ncbi.nlm.nih.gov/pubmed/37209526 http://dx.doi.org/10.1016/j.tranon.2023.101694 |
Ejemplares similares
-
Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers
por: Gunning, Alicia, et al.
Publicado: (2023) -
5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients
por: Chen, Hang-Yu, et al.
Publicado: (2021) -
Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022) -
cfDNA Methylation Profiles and T-Cell Differentiation in Women with Endometrial Polyps
por: Li, Xiao-Hong, et al.
Publicado: (2022) -
Microfluidic Technologies for cfDNA Isolation and Analysis
por: Xu, Zheyun, et al.
Publicado: (2019)